During the past decade, Duke Medicine - Duke Molecular Physiology Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Medicine - Duke Molecular Physiology Institute" #1 collaborator was "Vida Health, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Duke Medicine - Duke Molecular Physiology Institute" are "Anorexia Nervosa" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Duke Medicine - Duke Molecular Physiology Institute" in a lesser frequency.

Most popular intervention types in "Duke Medicine - Duke Molecular Physiology Institute" are "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mobile Health Application" (1 trials) and "One hour supervised exercise session" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Medicine - Duke Molecular Physiology Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Duke Medicine - Duke Molecular Physiology Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke Medicine - Duke Molecular Physiology Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke Medicine - Duke Molecular Physiology Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".